J. R. Germá Lluch

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 320 citations · Full text

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)

Gedske Daugaard, Iwona Skoneczna, Nina Aass et al. · Annals of Oncology · 2010 · 145 citations · Full text

Sequential High-dose Cisplatin, Radiation Therapy, Medicine +8

Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

Gemma Llort, Carmen Yagüe Muñoz, Mercè Peris Tuser et al. · Human Mutation · 2002 · 44 citations · Full text

Breast Oncology, Engineering, Genetics +16

Treatment of Stage I Testicular Tumours

J. R. Germá Lluch, M.Á. Climent, H. Villavicencio et al. · British Journal of Urology · 1993 · 41 citations

Surgical Oncology, Surveillance Policy, Surgery +16